Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioma, Subependymal × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33 Leukemia 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Myeloid, Chronic-Phase 12 Gastrointestinal Stromal Tumors 12 Philadelphia Chromosome 5 Leukemia, Myeloid 5 Brain Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Blast Crisis 4 Recurrence 3 Prostatic Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Glioblastoma 3 Bone Marrow Diseases 3 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2 Leukemia, Myeloid, Accelerated Phase 2 Gliosarcoma 2 Glioma 2 Digestive System Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

Temozolomide 1 Reverse Transcriptase Polymerase Chain Reaction 1 Modafinil 1 Lapatinib 1 Immunologic Techniques 1 Immunoenzyme Techniques 1 Fentanyl 1 Donepezil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡